Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06079346
Title A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer (STOP-PC)
Acronym STOP-PC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oncotelic Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.